UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)

Cornea, 2023-04, Vol.42 (4), p.435-443

2023

Volltextzugriff (PDF)

A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease

Cornea, 2021-09, Vol.40 (9), p.1132-1140

2021

Volltextzugriff (PDF)

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

American journal of ophthalmology, 2024-07, Vol.263, p.23-34

2024

Volltextzugriff (PDF)

A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2019-06, Vol.126 (6), p.792-800

2019

Volltextzugriff (PDF)

Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study

Journal of ocular pharmacology and therapeutics, 2022-04, Vol.38 (3), p.240-251

2022

Volltextzugriff (PDF)

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

Ophthalmology (Rochester, Minn.), 2023-05, Vol.130 (5), p.516-524

2023

Volltextzugriff (PDF)

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials

JAMA ophthalmology, 2020-11, Vol.138 (11), p.1168

2020

Volltextzugriff (PDF)

Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial

JAMA ophthalmology, 2023-05, Vol.141 (5), p.459

2023

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of a Water-Free Cyclosporine 0.1% Ophthalmic Solution for Treatment of Dry Eye Disease: ESSENCE-2 OLE

Cornea, 2024-05

2024

Volltextzugriff (PDF)

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

American journal of ophthalmology, 2019-08, Vol.204, p.97-104

2019

Volltextzugriff (PDF)

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

Cornea, 2021-10, Vol.40 (10), p.1290-1297

2021

Volltextzugriff (PDF)

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

The ocular surface, 2022-10, Vol.26, p.166-173

2022

Volltextzugriff (PDF)

Two Randomized, Double-masked, Placebo-controlled Studies of the Local Anesthetic Effect of Articaine Ophthalmic Solution

Clinical ophthalmology (Auckland, N.Z.), 2023-01, Vol.17, p.1357-1365

2023

Volltextzugriff (PDF)

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.2743-2751

2021

Volltextzugriff (PDF)

Mydriasis with micro-array print touch-free tropicamide-phenylephrine fixed combination MIST: pooled randomized Phase III trials

Therapeutic delivery, 2021-03, Vol.12 (3), p.201-214

2021

Volltextzugriff (PDF)

Single Administration of Bimatoprost Implant: Effects on 24-Hour Intraocular Pressure and 1-Year Outcomes

Ophthalmology. Glaucoma, 2023-11, Vol.6 (6), p.599-608

2023

Volltextzugriff (PDF)

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.4035-4048, Article 4035

2021

Volltextzugriff (PDF)

Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies

Ophthalmology science (Online), 2021-12, Vol.1 (4), p.100065-100065

2021

Volltextzugriff (PDF)

Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia

Ophthalmology science (Online), 2021-12, Vol.1 (4), p.100065, Article 100065

2021

Volltextzugriff (PDF)

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction

Ophthalmology (Rochester, Minn.), 2023-05, Vol.130 (5), p.516-524

2023

Volltextzugriff (PDF)

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Drugs (New York, N.Y.), 2021-11, Vol.81 (17), p.2017-2033

2021

Volltextzugriff (PDF)

Single Administration of Bimatoprost Implant

Ophthalmology. Glaucoma, 2023-11, Vol.6 (6), p.599-608

2023

Volltextzugriff (PDF)

Eyelid neuroma associated with swim goggle use

Archives of ophthalmology (1960), 1998-11, Vol.116 (11), p.1537

1998

Volltextzugriff (PDF)

Clinical and radiologic lacrimal testing in patients with epiphora

Ophthalmology (Rochester, Minn.), 1998-09, Vol.105 (9), p.1574-1574

1998

Volltextzugriff (PDF)

3 Things You Should Know About Dry Eye Disease

Ophthalmology Times, 2021-06, Vol.46 (10), p.30-31

Wirta, David L

2021

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(39)
magazinearticle
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Ophthalmology
(23)
Humans
(19)
Double-Blind Method
(13)
Male
(11)
Female
(10)
Middle Aged
(10)
Adult
(9)
Treatment Outcome
(9)
Aged
(8)
Glaucoma
(8)
Medicin Och Hälsovetenskap
(8)
Ocular Hypertension - Drug Therapy
(7)
Ophthalmic Solutions
(7)
Glaucoma, Open-Angle - Drug Therapy
(6)
Intraocular Pressure - Drug Effects
(6)
Aged, 80 And Over
(5)
Antihypertensive Agents - Adverse Effects
(5)
Dry Eye Disease
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)

A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease

Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials

Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial

Long-Term Safety and Efficacy of a Water-Free Cyclosporine 0.1% Ophthalmic Solution for Treatment of Dry Eye Disease: ESSENCE-2 OLE

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

Two Randomized, Double-masked, Placebo-controlled Studies of the Local Anesthetic Effect of Articaine Ophthalmic Solution

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Mydriasis with micro-array print touch-free tropicamide-phenylephrine fixed combination MIST: pooled randomized Phase III trials

Single Administration of Bimatoprost Implant: Effects on 24-Hour Intraocular Pressure and 1-Year Outcomes

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies

Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Single Administration of Bimatoprost Implant

Eyelid neuroma associated with swim goggle use

Clinical and radiologic lacrimal testing in patients with epiphora

3 Things You Should Know About Dry Eye Disease

Suchergebnisse filtern